Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ribosomal resistance of clinical enterococcal to streptomycin isolates.

Literature DB >> 6326668

Ribosomal resistance of clinical enterococcal to streptomycin isolates.

G M Eliopoulos, B F Farber, B E Murray, C Wennersten, R C Moellering.

Abstract

The mechanism of high-level resistance to streptomycin was studied in 12 clinical isolates of Streptococcus faecalis. Six strains produced streptomycin-modifying enzymes. Each of three enzyme-negative strains tested demonstrated ribosomal resistance to streptomycin. Lack of ribosomal susceptibility is a significant cause of high-level streptomycin resistance among clinical enterococcal isolates.

Entities: Chemical Species

Mesh：

Substances：

Year: 1984 PMID： 6326668 PMCID： PMC185531 DOI： 10.1128/AAC.25.3.398

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

13 in total

1. Resistance to six aminoglycosidic aminocyclitol antibiotics among enterococci: prevalence, evolution, and relationship to synergism with penicillin.

Authors: S A Calderwood; C Wennersten; R C Moellering; L J Kunz; D J Krogstad
Journal: Antimicrob Agents Chemother Date: 1977-09 Impact factor: 5.191

Review 2. Mechanisms of antibiotic resistance in bacteria.

Authors: R Benveniste; J Davies
Journal: Annu Rev Biochem Date: 1973 Impact factor: 23.643

3. Evidence for mutation to streptomycin resistance in clinical strains of Staphylococcus aureus.

Authors: R W Lacey; I Chopra
Journal: J Gen Microbiol Date: 1972-11

4. Prevalence of high-level resistance to aminoglycosides in clinical isolates of enterococci.

Authors: R C Moellering; C Wennersten; T Medrek; A N Weinberg
Journal: Antimicrob Agents Chemother (Bethesda) Date: 1970

Review 5. Aminoglycoside uptake and mode of action--with special reference to streptomycin and gentamicin. I. Antagonists and mutants.

Authors: R E Hancock
Journal: J Antimicrob Chemother Date: 1981-10 Impact factor: 5.790

6. Mechanisms and spectrum of streptomycin resistance in a natural population of Pseudomonas aeruginosa.

Authors: J T Tseng; L E Bryan; H M Van den Elzen
Journal: Antimicrob Agents Chemother Date: 1972-09 Impact factor: 5.191

7. Mechanism of resistance to antibiotic synergism in enterococci.

Authors: R A Zimmermann; R C Moellering; A N Weinberg
Journal: J Bacteriol Date: 1971-03 Impact factor: 3.490

8. Aminoglycoside-inactivating enzymes in clinical isolates of Streptococcus faecalis. An explanation for resistance to antibiotic synergism.

Authors: D J Krogstad; T R Korfhagen; R C Moellering; C Wennersten; M N Swartz
Journal: J Clin Invest Date: 1978-08 Impact factor: 14.808

9. Recognition of group D streptococcal species of human origin by biochemical and physiological tests.

Authors: R R Facklam
Journal: Appl Microbiol Date: 1972-06

10. Resistance to penicillin-streptomycin synergy among clinical isolates of viridans streptococci.

Authors: B F Farber; G M Eliopoulos; J I Ward; K Ruoff; R C Moellering
Journal: Antimicrob Agents Chemother Date: 1983-12 Impact factor: 5.191

25 in total

1. Enterococcal endocarditis: can we win the war?

Authors: Jose M Munita; Cesar A Arias; Barbara E Murray
Journal: Curr Infect Dis Rep Date: 2012-08 Impact factor: 3.725

Review 2. Screening and treatment of infections caused by resistant enterococci.

Authors: D J Herman; D N Gerding
Journal: Antimicrob Agents Chemother Date: 1991-02 Impact factor: 5.191

Review 3. Antimicrobial resistance among enterococci.

Authors: D J Herman; D N Gerding
Journal: Antimicrob Agents Chemother Date: 1991-01 Impact factor: 5.191

4. Factors influencing determination of high-level aminoglycoside resistance in Enterococcus faecalis.

Authors: D F Sahm; S Boonlayangoor; P C Iwen; J L Baade; G L Woods
Journal: J Clin Microbiol Date: 1991-09 Impact factor: 5.948

5. Detection of a streptomycin/spectinomycin adenylyltransferase gene (aadA) in Enterococcus faecalis.

Authors: N C Clark; O Olsvik; J M Swenson; C A Spiegel; F C Tenover
Journal: Antimicrob Agents Chemother Date: 1999-01 Impact factor: 5.191

Review 6. Antibiotic combinations: should they be tested?

Authors: G M Eliopoulos; C T Eliopoulos
Journal: Clin Microbiol Rev Date: 1988-04 Impact factor: 26.132

Review 7. Susceptibility of enterococci and epidemiology of enterococcal infection in the 1980s.

Authors: R C George; A H Uttley
Journal: Epidemiol Infect Date: 1989-12 Impact factor: 2.451

8. In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures.

Authors: E Potgieter; M Carmichael; H J Koornhof; L J Chalkley
Journal: Eur J Clin Microbiol Infect Dis Date: 1992-06 Impact factor: 3.267

9. Comparison of Enterococcus raffinosus with Enterococcus avium on the basis of penicillin susceptibility, penicillin-binding protein analysis, and high-level aminoglycoside resistance.

Authors: M L Grayson; G M Eliopoulos; C B Wennersten; K L Ruoff; K Klimm; F L Sapico; A S Bayer; R C Moellering
Journal: Antimicrob Agents Chemother Date: 1991-07 Impact factor: 5.191

10. Bactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinations.

Authors: M K Hayden; G I Koenig; G M Trenholme
Journal: Antimicrob Agents Chemother Date: 1994-06 Impact factor: 5.191